Tag: Efflux (microbiology)

AIInnovationScience

AI Model Accelerates Antibiotic Discovery with 90-Fold Hit Rate Improvement

Researchers have developed a deep learning system that screened 1.4 billion compounds in under 48 hours, achieving a 90-fold improvement in identifying antibacterial hits. The AI model successfully predicted activity across diverse chemical spaces, including compounds structurally dissimilar to known antibiotics.

Breakthrough in Antibacterial Discovery

In what sources indicate could revolutionize antibiotic development, researchers have created a deep learning system that dramatically improves the efficiency of identifying antibacterial compounds. According to reports published in Nature Biotechnology, the AI model screened 1.4 billion molecules in under 48 hours and achieved a 90-fold improvement in hit rates compared to traditional high-throughput screening methods.

by Chloe Danner
HealthcareResearch

Platinum-Drug Conjugates Show Promise in Overcoming Chemotherapy Resistance

Scientists have created innovative platinum-drug hybrids that effectively bypass cancer’s drug resistance mechanisms. These conjugates leverage platinum’s protein-binding properties to evade cellular efflux pumps that typically expel chemotherapy drugs.

Breaking Through Cancer’s Defense Systems

Researchers have developed a novel approach to overcoming multidrug resistance (MDR) in cancer treatment by leveraging platinum’s unique chemical properties, according to a recent study published in Nature Communications. The strategy involves creating hybrid molecules that combine platinum pharmacophores with established chemotherapy drugs, enabling them to bypass the cellular efflux pumps that typically render cancer cells resistant to treatment.

by Emma Langford